Clinical Trial Update: Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML [Phase 1]

View source ↗

Summary

This is a Phase I trial evaluating epigenetic priming with Decitabine in combination with induction chemotherapy for acute myeloid leukemia. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED